Momenta Pharmaceuticals to Webcast Presentation at the 2013 Deutsche Bank BioFEST Conference
25. November 2013 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
06. November 2013 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports Third Quarter 2013 Financial Results
05. November 2013 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of Third Quarter 2013 Financial Results Conference Call and Webcast
15. Oktober 2013 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 15, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals to Webcast Presentations at Three Upcoming Investor Conferences
04. September 2013 09:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
06. August 2013 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports Second Quarter 2013 Financial Results
01. August 2013 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs,...
Momenta Pharmaceuticals Announces Potential for 2014 Market Entry of Generic Copaxone(R)
26. Juli 2013 13:18 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 26, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today announced that the United States Court of Appeals for the Federal Circuit (the "Federal Circuit")...
Momenta Pharmaceuticals Announces Date of Second Quarter 2013 Financial Results Conference Call and Webcast
16. Juli 2013 09:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 16, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals Announces Issuance of U.S. Patent for Sialylation Technology
25. Juni 2013 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., June 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...